Spinal Muscular atrophy symptom

Jump to: navigation, search

Spinal Muscular Atrophy Microchapters

Home

Patient Info

Overview

Epidemiology and Demographics

Risk Factors

Screening

Other forms

Molecular Biology

Genetics

Types

Diagnosis

Diagnosis

Full Differential Diagnosis

Symptom

Physical Examination

Electrolyte & Biomarker Studies

Electrocardiogram

Chest X Ray

MRI and CT

Echocardiography or Ultrasound

Other Imaging Findings

Pathology

Other Diagnostic Studies

Treatment

Outcome measures

Therapeutics development

Indications For Surgery

Research

Pre-Operative Assessment

Post-Operative Assessment

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Spinal Muscular atrophy symptom Resources

Most recent articles on Spinal Muscular atrophy symptom

Most cited articles on Spinal Muscular atrophy symptom

Review articles on Spinal Muscular atrophy symptom

Review articles on Spinal Muscular atrophy symptom

CME Programs on Spinal Muscular atrophy symptom

Powerpoint slides on Spinal Muscular atrophy symptom

Images of Spinal Muscular atrophy symptom

Ongoing Trials on Spinal Muscular atrophy symptom at Clinical Trials.gov

US National Guidelines Clearinghouse on Spinal Muscular atrophy symptom

NICE Guidance on Spinal Muscular atrophy symptom

FDA on Spinal Muscular atrophy symptom

CDC on Spinal Muscular atrophy symptom

Spinal Muscular atrophy symptom in the news

Blogs on Spinal Muscular atrophy symptom

Directions to Hospitals Treating Spinal Muscular atrophy symptom

Risk calculators and risk factors for Spinal Muscular atrophy symptom

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]



Infantile SMA is the most severe form. Some of the symptoms include:

In general, the earlier the symptoms appear, the shorter the life span. The onset is sudden and dramatic. Once symptoms appear the motor neuron cells quickly deteriorate shortly after. The disease can be fatal and there is no cure for SMA yet known. The major management issue in Type 1 SMA is the prevention and early treatment of respiratory infections; pneumonia is the cause of death in the majority of the cases. Infants with Type 1 SMA have a life expectancy of less than two years, however, some grow to be adults. Intellectual and later, sexual functions, are unaffected by SMA.

References

External links

  • sma at NINDS
  • SMA Support
  • Spinal Muscular Atrophy - Fight SMA - An international nonprofit dedicated to finding a treatment or cure for spinal muscular atrophy. Visit Fight SMA's website and also the Spinal Muscular Atrophy Blog for the latest news and research information about the leading genetic killer of children under two.
  • Families of Spinal Muscular Atrophy - An international nonprofit dedicated to advancing research and supporting individuals and families with sma. FSMA has a web site with news, information and message boards for individuals to post questions. FSMA is one of the largest US private funders of SMA research and has more than 30 chapters worldwide.FSMA
  • SMA Trust - a UK registered charity working to fund medical research into Spinal Muscular Atrophy
  • Jennifer Trust for Spinal Muscular Atrophy - A national charity in the UK dedicated both to supporting people affected by SMA, and investing in essential research into causes, treatments and eventually a cure for the condition

da:Spinal muskulær atrofi de:Spinale Muskelatrophie el:Νωτιαία μυϊκή ατροφία nl:Spinale Musculaire Atrofieën fi:Spinaaliset lihasatrofiat sv:Spinal muskelatrofi



Linked-in.jpg